Customer Success Stories

Punxsutawney Area Hospital Utilizes PowerLook® Density Assessment (formally iReveal®) to Improve Breast Density Reporting Accuracy and Quality of Care

For over 100 years, Punxsutawney Area Hospital (PAH) has been committed to providing the best care for patients in the three-county area of western Pennsylvania. The 49-bed rural hospital sees about 17,000 patients per year with its radiologists reading approximately 225 mammograms each month.

Read More


Reid Health Recognizes PowerLook® Density Assessment (formally iReveal®) as a Valuable Breast Density Solution for Both Patients and Clinicians

Reid Health, previously known as Reid Memorial Hospital, includes a 217-bed hospital on its main campus and numerous satellite locations in the region of Eastern Indiana and Western Ohio. Reid’s service area is home to about 280,000 people and includes six Indiana and two Ohio counties..

Read More


Swedish-American Hospital Adopts PowerLook® Density Assessment to Help Radiologists More Consistently Identify Patients with Dense Breasts

Swedish-American Hospital (SAH), a division of UW Health, is dedicated to providing excellence in healthcare and compassionate care to the community. The hospital includes 30 primary care and multi-specialty clinics including the Center for Women and serves residents of 12 counties in northern Illinois and southern Wisconsin.

Read More

Quick Links

iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and while enhancing patient care. iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers.

Facebook Twitter LinkedIn

© 2017, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo and Never Stop Looking is a trademark of iCAD, Inc.

Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.